Morpholine derivatives as norepinephrine reuptake inhibitors

Details for Australian Patent Application No. 2004289616 (hide)

Owner Eli Lilly and Company

Inventors Campbell, Gordon Iain; Man, Teresa; Walter, Magnus Wilhelm; CasesThomas, Manuel Javier; Masters, John Joseph; Rudyk, Helene Catherine Eugenie

Agent Spruson & Ferguson

Pub. Number AU-B-2004289616

PCT Pub. Number WO2005/047272

Priority 60/535,459 09.01.04 US; 0326148.4 10.11.03 GB

Filing date 28 October 2004

Wipo publication date 26 May 2005

Acceptance publication date 5 August 2010

International Classifications

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/047272 Priority application(s): WO2005/047272

5 August 2010 Application Accepted

  Published as AU-B-2004289616

2 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289621-Improved carton lock

2004289612-4-sided container with smooth front and back panels that can receive labels in a variety of ways